evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Saxenda© – A New Treatment Obesity Upcoming wave of hormone-based therapies
Description
This prolongs and amplifies the physiologic effects of endogenous GLP-1
OAT, organic anion transporter
GLP-1 reduces glucose production from glycogen in which organ
J Headache Pain 24(1):89
GLP-1 receptor agonists, including semaglutide and liraglutide, are FDA-approved medications for type 2 diabetes and obesity management
